Pharmaceuticals, Biotechnology, Healthcare, Drug Discovery, Medical Research
About Us
Cyclica (acquired by Recursion) is a biotechnology company that uses artificial intelligence and computational biophysics to revolutionize drug discovery. Their innovative platform combines ligand design for multi-targeted drug creation and ligand express for off-target profiling. This approach allows for the efficient development of novel therapeutics while minimizing unwanted side effects. Cyclica's technology enables faster, more cost-effective drug discovery processes, focusing on areas such as central nervous system disorders, oncology, and autoimmune diseases.
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.